The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at ...

You get hepatitis C by coming into direct contact with an infected person’s blood or bodily fluids that contain blood. Sharing drug-injection equipment is the cause of most hepatitis C infections in ...

This article will discuss the recommended hepatitis vaccine schedule for children and adults, including doses, timing, side effects, and who should get the vaccine. The following vaccines are approved ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

The drug is not approved in COVID-19 but is marketed under the brand name PegiHep for treatment of hepatitis B and C. According to a COVID-19 therapy tracker from the Milken Institute think ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

The number of people who have used the new safer drug consumption room in Glasgow has been revealed. Previously the total ...